This study compares work-life labour income of Indigenous and average Australians and assesses potential impact of bridging mortality gaps on their work-life earning gaps using a life-table model which took account of the survival, employment and income trajectories from 25 to 64 years.

The cost of government inaction on the social determinants of health, leading to health inequalities for the most disadvantaged Australians of working age, is substantial. This was measured in terms not only of the number of people affected but also their overall well-being, their ability...

It is now thirteen years since the welfare-to-work change to the Disability Support Pension (DSP) was first introduced in 2006. While the DSP remains the main social security payment for working-aged individuals with disability, the evidence base on the impact of policy changes to the...

This position paper, Funding High Cost Biotechnology under the Pharmaceutical Benefits Scheme, was prepared to aid discussions by stakeholders in the scheme at a forum in Sydney on 7 March 2002. The aim was to identify and assess possible mechanisms or models for funding new...

In Social Modelling and Public Policy: What is microsimulation modelling and how is it being used? Laurie Brown and Ann Harding provide an overview of social modelling, and in particular a general introduction to and insight into the potential role and usefulness of microsimulation in...

This report analyses the 2016 Census and other data using the Child Social Exclusion Index, to provide insight into the perspectives of children experiencing poverty, disadvantage and social exclusion in Australia.

Alzheimer’s Australia commissioned NATSEM to estimate the cost of dementia in Australia. The economic impact of dementia is a major concern nationally and internationally as the number of individuals with dementia continues to rise.

Finding ways of curbing government expenditure on the PBS while maintaining social equity and access to 'essential' medicines is at the centre of ongoing public debate. This paper outlines future developments that will extend the current model to include health outcomes. Adding health outcomes represents...

In recent years outlays on the Pharmaceutical Benefits Scheme have increased rapidly, prompting both attempts by government to reduce growth in outlays and renewed interest in the characteristics of the beneficiaries of the Scheme. This paper, using a microsimulation model of the PBS, analyses the...